Managing Neurologic Disease in the Era of COVID-19: Focus on Botulinum Toxin | Register for Neurology CME on eMedEvents


Neurological Immunotherapy: Managing Neurologic Disease in the Era of COVID-19: Focus on Botulinum Toxin is organized by CME Outfitters, LLC and designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)&trade.


Comments

Popular posts from this blog

Urgent Care Symposium, Puerto Rico | eMedEvents